# EYSUVIS
> **NDA210933** · New Drug Application · Sponsor: ALCON LABS INC · Approved 2020-10-26
## Drug
- **FDA Application Number:** NDA210933
- **Application type:** New Drug Application
- **Brand name:** EYSUVIS
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** ALCON LABS INC
- **Manufacturer:** ALCON LABORATORIES, INC.
- **First approval:** 2020-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210933)
---
*MORVS · CC0 1.0*